Multiple Myeloma Program

Clinical Studies

What is a clinical trial?

Clinical trials are performed as a central component of clinical research. Such prospective research studies are designed to answer specific questions about new treatments. Clinical trials generate data on the safety and efficacy of new therapies. They are conducted only after they have received health authority/ethics committee approval. These authorities are responsible for vetting the risk/benefit ratio of the trial. Clinical studies aim to ensure the scientific validity and reproducibility of the results. Participation in a clinical trial is always completely voluntary and a patient can withdraw from a clinical trial at any point in time without giving a specific reason.

What clinical trials are available for patients with myeloma at HCI?

Research at HCI aims at finding a cure for myeloma. We do two kinds of research: clinical trials and laboratory research. Both types of research focus on developing immunotherapies, which will, in addition to standard treatments, help to keep myeloma under control for prolonged periods of time or even achieve a cure. Patients may be asked to participate in a clinical trial, but it is entirely up ton the patient to decide whether they would like to participate or not. We currently have a number of open trials for myeloma patients at all the different phases of the disease:

myeloma clinical studies

For more information, or to schedule an appointment, call 801-587-4652